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Georgia Southern University 
Jiann-Ping Hsu College of Public Health 
BIOS 7231 – Clinical Trial Methodology 
                                                                   Spring 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prerequisites:                  BIOS 6541; BIOS 7534 
 
VISTA Address:       Via  MyGeorgiaSouthern on GSU Home Page 
 
Catalog Description: Students are introduced to regulatory, scientific, statistical and 
practical aspects of methods inherent in design, monitoring and 
analysis of clinical trials.  Clinical trials in many areas of drug 
development are presented, discussed and critiqued. 
   
Required Textbook:       Clinical Trial Methodology by Karl E. Peace and Din Chen   
                                          Series: Chapman & Hall/CRC Biostatistics Series  
                                          Cat. #:  C9179 
                                          ISBN:  9781584889175 
                                          ISBN 10:  1584889179 
                                          Publication Date:  July 19, 2010  
                                          Number of Pages:  420   
 
                                         The course is presented using power points. Students are  
                                         provided copies of the power points on a Flash Drive. 
 
 
Instructor:  Karl E. Peace 
Office:  Hendrix Hall #1005 
Phone:  912-478-7905 
E-Mail Address: kepeace@georgiasouthern.edu  or peacekarl@frontier.com    
Office Hours:         Wednesday – 3:00 PM – 5:00 PM  
                                    And – By appointment, any time via email 
Web Page:  http://www.georgiasouthern.edu/~kepeace/   
Class Meets:  Wednesday – 5:00 PM-to-7:30 PM via electronic classroom 2 weeks of each  
                                    Month and onsite 2 weeks of each month. 
    
 
-- Course schedules can be found at: http://www.collegesource.org/displayinfo/catalink.asp -- 
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Secondary Texts:  
 
Chen D, Peace KE (2010): Clinical Trial Data Analysis using R; Chapman & Hall/CRC, Taylor 
and Francis Group; ISBN:  978-1-4398-4020-7 
 
Chen, D, Peace KE: Applied Meta-Analysis using R. Chapman & Hall/CRC, Taylor and Francis 
Group; 13: 978-1-4665-0599-5; May, 2013. 
 
Chen D, Sun J, Peace KE [Editors and Author contributors]   (2012): Interval-Censored Time-to-
Event Data: Methods and Applications"; Chapman & Hall/CRC, 
Taylor and Francis Group; Published July, 2012. 
 
Peace, K. E. [Editor and Author contributor] (2008): Design and Analysis of Clinical Trials with 
Time to Event Endpoints; Chapman & Hall/CRC Taylor and Francis 
Group; Boca, ISBN 978-1-4200-6639-5. 
 
Peace, K. E. [Editor and Author contributor] (1992): Biopharmaceutical Sequential Statistical 
Applications. Marcel Dekker, Inc., New York, ISBN 0-8247-8628-9. 
 
Peace, K. E. [Editor and Author contributor] (1990): Statistical Issues in Pharmaceutical Drug 
Development.  Marcel Dekker, Inc., New York, ISBN 0-8247-8290-9. 
 
Peace, K.E. [Editor and author] (1988): Biopharmaceutical Statistics in Drug Development. 
Marcel Dekker, Inc., New York, ISBN 0-8247-7798-0. 
 
M.P.H. Biostatistics Concentration Competencies:  
 
Upon graduation a student with an M.P.H. in Biostatistics should be able to: 
 
1. Construct a public health and biomedical research question from ideas, conditions, and 
events that exist in a rural and urban community, region, state, and nation using critical 
thinking skills; 
 
2. Identify objectives of a public health and biomedical research question; 
 
3. Express objectives in the appropriate biostatistical framework such as hypothesis testing, 
estimation, and prediction; 
 
4. Evaluate objectives of a public health research question to ensure the appropriate type of 
data is collected for analysis; 
 
5. Design an experiment or survey pertaining to a public health and biomedical research 
question in order to collect the data needed to meet objectives of public health research; 
 
6. Apply appropriate statistical tools and software in order to analyze data; 
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7. Demonstrate use of Statistical Analysis Software (SAS) to input, manage, merge, export, 
and conduct analysis on public health and biomedical data; 
 
8. Analyze data using appropriate categorical analysis techniques to obtain valid and 
reliable results; 
 
9. Analyze quantitative data using appropriate biostatistical methods such as simple and 
multiple regression and clinical trial methodology; 
 
10. Provide statistical requisites for developing a protocol for conducting a clinical trial; 
 
11. Describe key concepts and theory underlying biostatistical methodology used in 
probability and inferential, analytical, and descriptive statistics; 
 
12. Interpret results of biostatistical analyses so that valid and reliable conclusions regarding 
a public health and biomedical research question may be drawn from the analyses; 
 
13. Develop written and oral reports to communicate effectively to research investigators 
pivotal aspects of a study, including its design, objectives, data, analysis methods, results, 
and conclusions; 
 
14. Create a collaborative environment for working on written and oral reports and 
developing critical thinking skills. 
 
 
Course Objectives:   At the end of this course, students will be able to: 
 
1. Translate public health and biomedical research objectives into statistical hypotheses  
(competencies 1, 2, 3, 4) 
 
2. Design public health and biomedical research clinical trials  (competencies 1, 2, 3, 4, 
5)   
 
3. Develop Statistical Analysis Sections for pubic health and biomedical research 
Protocols (competencies 1, 2, 3, 4, 5, 8, 9, 10) 
 
4. Explain the requirements for good protocol development for public health and 
biomedical research clinical trials (competencies 1, 2, 3, 4, 5, 8, 9, 10, 13, 14) 
 
5. Apply common statistical descriptive and inferential analysis methods to data 
collected in public health and biomedical research clinical trials (competencies 6, 7, 
8, 9) 
 
6. Describe methodological alternatives to commonly used statistical methods used in 
public health and biomedical research clinical trials when analysis assumptions are 
not met (competencies 6, 7, 8, 9) 
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7. Interpret results of statistical analyses of data collected from public health and 
biomedical clinical trials (competency 12) 
 
8. Develop written and oral presentations based on statistical analyses of public health 
and biomedical research clinical trials, for both public health professionals and 
educated lay audiences (competencies 12, 13, 14) 
 
9. Identify key federal regulation ‘governing’ the conduct of clinical trials (competency 
10) 
 
10. Explain the importance of the numbers of patients in clinical trials (competency 11)   
 
11. Explain the importance of monitoring adverse experiences in clinical trials 
(competencies 2, 5, 6 ,10) 
 
12. Describe methods for monitoring adverse experiences in clinical trials (competencies 
2, 5, 6, 10) 
 
13. Explain how data from multicentre clinical trials may be ‘pooled’ (competencies 6, 7, 
8, 9, 10, 13) 
 
14. Describe the issues in group sequential clinical trials  (competencies 11, 12, 13) 
 
Instructional Methods: Class meetings will be a combination of lecture and class discussion. 
Approximately half of the class meetings will be facilitated via Adobe Connect in real time 
(blended format) and the remainder physically in the classroom. Homework assignments, class 
participation and the final examination constitute the basis of student evaluation.   Students are 
expected to make use of office hours and email contact to discuss concepts or difficulties they 
may have. In addition, they may seek the assistance of the GA. 
 
Daily Study Log:  Students are required to keep a daily computerized study log.  The study log 
should have a column for the date, a column to identify topic of study, a column to identify the 
time of beginning study, a column to identify the ending time of study, and a column to identify 
the amount of time spent in studying the topic. 
 
 
Final Examination:   May ?? Last day of classes   
                                    May ??  Final exams 
                                     
            Grading: Weighting of assignments for purposes of grading will be as follows: 
 
 Final Exam (objectives 1-14, integrated)……………60% 
 Assignment (objectives 1-14, individually)……. …..30% 
                                          Class Participation (objectives 1-14, individually)…10% 
               ____ 
 Total Possible                     100% 
    
 5
                                          The following point scale will be utilized in grading: 
 
90% - 100% A 
80% -   90% B 
70% -   80% C 
60% -   70% D 
  
                                          There are times when extraordinary circumstances occur (e.g., serious 
illness, death in the family, etc.).  In such circumstances, and/or if you 
need additional time to satisfactorily complete any course requirement, 
please consult with the instructor within a reasonable amount of time.   
 
Academic Misconduct: As a student registered at this University, it is expected that you will 
adhere to only the strictest standards of conduct.  It is recommended 
that you review the latest edition of the Student Conduct Code book, as 
well as the latest Undergraduate & Graduate Catalog to familiarize 
yourself with the University’s policies in this regard.  Your continued 
enrollment in this course is an implied contract between you and the 
instructor on this issue; from this point forward, it is assumed that you 
will conduct yourself appropriately. 
 
Academic integrity relates to the appropriate use of intellectual 
property.  The syllabus, lecture notes, and all materials presented 
and/or distributed during this course are protected by copyright law.  
Students are authorized to take notes in class, but that authorization 
extends only to making one set of notes for personal (and no other) 
use.  As such, students are not authorized to sell, license, commercially 
publish, distribute, transmit, display, or record notes in or from class 
without the express written permission of the instructor. 
 
Academic Handbook: Students are expected to abide by the Academic Handbook, located at 
http://students.georgiasouthern.edu/sta/guide/.  Your failure to comply 
with any part of this Handbook may be a violation and thus, you may 
receive an F in the course and/or be referred for disciplinary action. 
 
University Calendar   
for the Semester: The University Calendar is located with the semester schedule, and 
can be found at: 
http://students.georgiasouthern.edu/registrar/calendar.htm 
 
 
Attendance Policy: Federal regulations require attendance be verified prior to distribution 
of financial aid allotments.  Attendance will not be recorded after this 
initial period. 
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One Final Note: The contents of this syllabus are as complete and accurate as possible.  
The instructor reserves the right to make any changes necessary to the 
syllabus and course material.  The instructor will make every effort to 
inform students of changes as they occur.  It is the responsibility of the 
student to know what changes have been made in order to successfully 
complete the requirements of the course. 
 
Overview of the Content to be Covered During the Semester: 
 
Module I: An Overview of the Regulation of Pharmaceuticals 
 
Module II: An Overview of the Processes of Discovery, Basic Research, Clinical Development 
and Manufacturing in Pharmaceutical Development 
 
Module III: Biostatistical Aspects of Clinical Drug Development 
A. The Components of a Protocol  
B. Statistical Analysis Section of a Clinical Trial Protocol 
 
Module IV: Bioavailability & Bioequivalence of Pharmaceutical Formulations 
 
Module V: The Design and Analysis of Pivotal Clinical Trials to Assess the Efficacy of Drugs to 
Treat Panic Disorder 
 
Module VI: Clinical Trials in the Prevention of NSAID Induced Gastric Ulceration 
 
Module VII: Biostatistical Aspects of the Development of H2-Receptor Antagonist Drugs in the 
Treatment of Duodenal Ulcers 
 
Module VIII: Biostatistical Aspects of the Development of Antianginal Drugs 
 
Module IX: Biostatistical Aspects of the Development of Drugs to Treat Alzheimer’s disease 
Based upon Enrichment Designs 
 
Module X: The Importance of Numbers (of Patients) in Cancer Clinical Trials 
 
Module XI: Biostatistical Aspects of the Design of Cancer Trials 
 
Module XII: Biostatistical Aspects of the Analysis and Interpretation of Cancer Clinical Trials 
 
Module XIII: Monitoring Adverse Experiences in Clinical Drug Development 
 
Module XIV: The Pooling of Data from Multicenter Clinical Trials 
 
Module XV: Interim Analyses: p-Value and Power Computations in Multiple Look Trials 
 
Module XVI: Statistical Analysis of Dose Response Trials 
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Student Information (CTM Class): 
 
      Print Full Name                     email address                Pledge to spend enough time                 
                                                                                         to master material? Circle one. 
 
1. ________________          ________________            Yes          No       Undecided 
 
2. ________________          ________________            Yes          No       Undecided 
  
3. ________________          ________________            Yes          No       Undecided 
 
4. ________________          ________________            Yes          No       Undecided 
 
5. ________________          ________________            Yes          No       Undecided 
 
6. ________________          ________________            Yes          No       Undecided 
 
7. ________________          ________________            Yes          No       Undecided 
 
8. ________________          ________________            Yes          No       Undecided 
  
9. ________________          ________________            Yes          No       Undecided                   
 
10. ________________        ________________            Yes          No       Undecided 
 
11. ________________        ________________            Yes          No       Undecided 
 
12. ________________        ________________            Yes          No       Undecided 
 
